By Dr. Sanchari Sinha Dutta, Ph.D. A randomized trial suggests that avoiding coffee after cardioversion may not help, and that modest caffeine intake may actually be associated with fewer atrial ...

This 2026 Retina Clear report details how ingredient transparency, screen-time trends, and the "Red Root Hack" are shaping ...

Current drugs for pancreatic cancer lose effectiveness within months because the tumour becomes resistant. The group from ...

Analysis from continued follow-up of Phase 1/2 clinical trial data in Hunter syndrome (MPS II) reinforces potential for tividenofusp alfa (DNL310) to address full disease spectrumLaunch readiness ...

The FDA accepted an application for ivonescimab with chemotherapy for patients with lung cancer driven by EGFR changes after ...

According to the 2025 Stack Overflow Developer Survey, the single greatest frustration for developers is dealing with AI solutions that look correct but are slightly wrong. Nearly half of developers ...

Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of investigational therapies and diagnostic assays for patients with Alzheimer's disease (AD) and other ...

BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from MAHA.

The gray market is awash with BPC-157, a drug hyped as a cure-all, but unapproved by the FDA. Will RFK Jr. change that?

Objectives To examine the associations between the inflammatory potentials of diet and lifestyle, as measured by the Dietary Inflammation Score (DIS) and Lifestyle Inflammation Score (LIS), with the ...